NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1922205681 M.D.
Verify on CMS → Amruth Palla, M.D.
Hematology & Oncology Physician in Midland, Michigan.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 273 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$20.47
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Amruth Palla, M.D. filed 1,247 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in Midland, Michigan, prescribing 89% generic.
- 1K
- Part D claims, 2023
- 89%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥78th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1922205681 · Hematology & Oncology Physician
NPI-10 · ENUM-MID · TAX-MID · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1922205681
- ENUM-MID 2007
- TAX-MID 11K Hematology &
- RX-MID 1,247
- BOOK-THIN 265 in Michigan
- PHOTO-ENUM Damian Silbermins · 2007
Amruth Palla, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
1,247 ≥ 78th percentile 78% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Amruth Palla, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Amruth Palla, M.D.?
Quality data not reportedPrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
1,247 47% vs specialty avg
Specialty distribution in Michigan
How Hematology & Oncology Physician compares to other specialties among Michigan providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1922205681 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/27/2007 |
Hospital and facility affiliations
Facilities where Amruth Palla, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Mymichigan Medical Center Midland
★★★★☆ 4/5
Midland, MI
Acute Care Hospitals
CMS CCN: 230222
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Amruth Palla, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$20
Largest payer
Tempus AI, Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Michigan MI-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 - they are NOT specific to Amruth Palla, M.D.. To verify Amruth Palla, M.D.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases
MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Amruth Palla, M.D. - brand share 11.0%
Hematology & Oncology Physician average
11% brand-name claims vs 89% generic, on 1,247 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,247
Total Claims
$1.4M
Total Drug Cost
273
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,036
- Total Day Supply
- 54,116
- Brand vs Generic
- 11% brand / 89% generic
- Brand Drug Cost
- $1.1M
- Generic Drug Cost
- $351K
- Opioid Claims
- 49 (3.9% rate)
- Antibiotic Claims
- 26
Patient Demographics
- Average Patient Age
- 73.3 years
- Avg HCC Risk Score
- 1.57
- Gender Split
- 77% female / 23% male
- Age Distribution
- <65: 19, 65-74: 138, 75-84: 98, 85+: 18
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Amruth Palla, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
244 claims
- Tamoxifen Citrate
Tamoxifen Citrate
138 claims
- Ondansetron Odt 68
Ondansetron Odt
68 claims
- Prochlorperazine M… 61
Prochlorperazine Maleate
61 claims
- Dexamethasone 57
Dexamethasone
57 claims
- Lidocaine-Prilocaine 48
Lidocaine-Prilocaine
48 claims
- Prednisone 46
Prednisone
46 claims
- Gabapentin 37
Gabapentin
37 claims
| Drug | Claims |
|---|---|
| Anastrozole | 244 |
| Tamoxifen Citrate | 138 |
| Ondansetron Odt Ondansetron | 68 |
| Prochlorperazine Maleate | 61 |
| Dexamethasone | 57 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 48 |
| Prednisone | 46 |
| Gabapentin | 37 |
| Abiraterone Acetate | 32 |
| Eliquis Apixaban | 29 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Amruth Palla, M.D. fits within the Hematology & Oncology Physician landscape nationally.
11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Amruth Palla, M.D.'s 1,247 claims are above the specialty average of 847.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Palla, both outside Michigan so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in Michigan
Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as Palla.
One of 265 Hematology & Oncology Physician providers enrolled in Michigan, 5 are shown here.
Dr. Ahmed Abdel-Maksoud
MD
Midland, MI
Dr. Jonathan Abramson
M. D.
Bay City, MI
Dr. Calvin Abro
MD
Battle Creek, MI
Lindsey Ackerman
Sterling Heights, MI
Dr. Paul Adams
M.D.
Flint, MI
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Amruth Palla, M.D.'s specialty? ▼
Amruth Palla, M.D. specializes in Hematology & Oncology Physician and practices in Midland, Michigan. Credentials: M.D..
How much does Amruth Palla, M.D. prescribe under Medicare Part D? ▼
In 2023, Amruth Palla, M.D. wrote 1,247 Medicare Part D claims totaling $1.4M in drug costs for 273 beneficiaries.
Where is Amruth Palla, M.D. located? ▼
Amruth Palla, M.D. is located at 4500 CAMPUS RIDGE DR, Midland, MI, 48670. Phone: (989) 839-6188.
What is Amruth Palla, M.D.'s NPI number? ▼
Amruth Palla, M.D.'s National Provider Identifier (NPI) is 1922205681, issued on 06/27/2007.
Does Amruth Palla, M.D. prescribe more brand-name or generic drugs? ▼
Amruth Palla, M.D.'s prescribing is 11% brand-name and 89% generic drugs by claim count, with $1.1M in brand drug costs.
Does Amruth Palla, M.D. prescribe opioids? ▼
Yes, Amruth Palla, M.D. had 49 opioid claims in 2023 with an opioid prescribing rate of 3.9%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Amruth Palla, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Amruth Palla, M.D.'s most frequently prescribed drugs include Anastrozole, Tamoxifen Citrate, Ondansetron Odt. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Amruth Palla, M.D. accept Medicare? ▼
Amruth Palla, M.D. appears in CMS Medicare data with 1,247 Part D claims and 273 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Amruth Palla, M.D.'s credentials? ▼
Amruth Palla, M.D.'s NPI is 1922205681 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.